Catalyst Wire Dossier Catalyst Wire Dossier

Seraprevir

Seraprevir · Ginkgopharma CO., LTD
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Seraprevir, covering 2019-06-28 to 2019-10-01. Get the full timeline:

Most recent: Clinical Trial Update: Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 2,3,6 Hepatitis C Virus Infection Patients [Phase 2]

See pricing